What is RMD's market cap?

$33.83B, based on the Nov 4 close of $240.51.

What is RMD's P/E ratio?

21.2× trailing-twelve-month earnings of $1.59B.

Does ResMed pay a dividend?

Yes. The latest regular dividend was $0.66 per share (ex-date Aug 20), an annualised yield of 1.10%.

How much of RMD is sold short?

11.9M shares, 8.5% of float, as of Oct 15, 2026.

What sector is RMD in?

Healthcare, in the Surgical Instruments industry.

NYSE · RMDHealthcareSurgical Instruments

ResMed Inc. (RMD)

$240.51+5.91%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$241.00▼ 2.19% in range

Nov 4, 2025Low $182.82 · High $275.96Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

ResMed closed at $240.51 on Nov 4, up 5.91%, 12.8% below its 52-week closing high. Volume of 2.3M shares was 1.68× its 20-day average (above normal).

Split-adjusted performance: +9.0% over one month, +14.7% over six months, -3.4% over one year.

In the quarter ended Sep 30, 2026, revenue was $1.41B, up 5.9% from a year earlier, with a net margin of 29.6%.

Short interest was 11.9M shares at the Oct 15 settlement, down 6.7% from the prior report (8.5% of float, 12.3 days to cover).

Market cap$33.83B140.7M shares

Revenue · quarter$1.41B+5.9% YoY

Diluted EPS$2.92+23.2% YoY

P/E · TTM21.2×P/S 5.9×

Net margin29.6%Gross 61.5%

Dividend yield1.10%$0.66 last paid

52-week range182.82 – 275.96−12.8% from high

Volume2.3M1.68× 20-day avg

Volatility · 60d32.6%Annualised

Short % of float8.5%12.3 days to cover

Net cash$601.1MCash $1.01B

Next earnings—Not scheduled

Split-adjusted performance

1W −3.9%1M +9.0%3M +7.7%6M +14.7%YTD −0.1%1Y −3.4%3Y +75.0%5Y −10.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum65

Revenue growth41

Net margin97

Value (low P/E)67

Size95

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short11.9M−6.7% vs prior

Days to cover12.3Settled Oct 15

% of float8.5%

Short vol. 10d65.7%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
RMDResMed	$240.51	+5.91%	+14.7%	+5.9%	29.6%	21.2	$33.83B
DXCMDexCom	$88.48	+6.64%	+46.6%	+11.2%	20.5%	33.3	$33.00B	Compare
MDLNMedline	$40.35	+18.36%	−4.0%	—	0.8%	—	$35.40B	Compare
WSTWest Pharmaceutical Services	$408.78	+0.44%	+30.8%	+8.7%	24.5%	44.6	$28.48B	Compare
BDXBecton, Dickinson and	$209.19	+5.56%	+44.5%	+5.4%	7.6%	60.6	$56.98B	Compare
BSXBoston Scientific	$45.82	+5.33%	−18.2%	+1.4%	11.3%	19.0	$66.40B	Compare
SOLVSolventum	$89.35	+5.42%	+25.9%	+2.2%	4.2%	10.6	$15.21B	Compare
GKOSGlaukos	$246.70	+5.86%	+82.4%	+58.0%	1.0%	—	$14.60B	Compare
BAXBaxter International	$26.50	+3.96%	+56.1%	+5.0%	9.9%	—	$13.71B	Compare

News about ResMed

All news →

ResMed: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 2d ago▲ Positive RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsZacks Investment Research · 5d ago▲ Positive ResMed (RMD) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research · 6d agoNeutral Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 23, 2026▲ Positive ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?Zacks Investment Research · Oct 23, 2026Neutral

Quick answers

What does ResMed do?: ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder.
What is RMD's market cap?: $33.83B, based on the Nov 4 close of $240.51.
What is RMD's P/E ratio?: 21.2× trailing-twelve-month earnings of $1.59B.
Does ResMed pay a dividend?: Yes. The latest regular dividend was $0.66 per share (ex-date Aug 20), an annualised yield of 1.10%.
How much of RMD is sold short?: 11.9M shares, 8.5% of float, as of Oct 15, 2026.
What sector is RMD in?: Healthcare, in the Surgical Instruments industry.

About ResMed

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.

HQ: San Diego, CA11,370 employeesListed Jun 2, 1995resmed.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology